Navigation Links
Sarah Cannon Research Institute Implements Virtify CTRR
Date:7/15/2013

LEXINGTON, Mass., July 15, 2013 /PRNewswire/ -- Virtify, Inc., a leading innovator in content and regulatory information management solutions for the life science industry, today announced that Sarah Cannon Research Institute (SCRI), a wholly owned subsidiary of HCA, has signed an enterprise-level contract for its Clinical Trial Registration & Results (CTRR) disclosure software. SCRI will utilize Virtify's CTRR to disclose their clinical trial information to the National Institute of Health's clinicaltrials.gov system as mandated by federal regulation.

(Logo:  http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

The old paradigm for managing disclosure throughout the clinical trial process has changed, including at academic and research organizations. Many now recognize that the large number of disparate, investigator-driven studies at these institutions, coupled with constant updates to these studies and increasingly complex disclosure requirements, render manual processes too cumbersome and error-prone.

"Sarah Cannon Research Institute is pleased to partner with Virtify to help automate the clinical trial disclosure processes within the SCRI Services Organization in order to fulfill its regulatory requirements," said Sheetal Khedkar, M.D., M.S.P.H, Director for Pharmacovigilance, Medical Writing and Scientifics at SCRI. "Virtify CTRR will help automate registration and results posting, significantly reducing the effort it takes to publish the trial information to clinicaltrials.gov."

Virtify's CTRR software helps streamline and automate the mandatory registration and results disclosure postings to the clinicaltrials.gov website and to other registries. The software also has the ability to provide a compliance view across all studies at an institution, allowing for better reporting and proactive compliance. Virtify's CTRR software offers academic/research institutions the most complete overall solution for managing compliance with regulatory reporting requirements including supporting integrations to "Off the Shelf" or custom applications.

"Virtify's CTRR system will enable SCRI to comply with clinical disclosure requirements in an efficient, consistent and predictable manner," said Satish Tadikonda, President and CEO of Virtify, Inc. "Simultaneously, Virtify CTRR will help streamline and optimize their disclosure activities, resources, and time. This increases business efficacy and productivity. The ability of Virtify CTRR to communicate with other SCRI systems means that duplicate data entry can be eliminated as well."

About SCRI

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology and cardiology through affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. SCRI is a wholly owned subsidiary of HCA. For more information, please visit http://sarahcannonresearch.com/

About Virtify

Virtify is the leading innovator in content and regulatory information management solutions for life sciences. Many of the world's leading organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's life science domain expertise has been leveraged by such companies as Genzyme/Sanofi, Novartis, Pfizer/Wyeth, Regeneron, academic research centers and CROs.  Virtify's easy-to-use software suite is the industry's only solution to provide a secure, collaborative, web-based environment for managing regulated content throughout the entire continuum – from pre-clinical through product registration to commercialization. Visit us at http://www.virtify.com


'/>"/>
SOURCE Virtify, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. York Nanocentre researchers image individual atoms in a living catalytic reaction
3. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
4. Comprehensive Topical Reports by Transparency Market Research Now Available at MarketPublishers.com
5. Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
6. BioInformatics, LLC New Market Research Report – Life Science Instruments: Brand Performance
7. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
8. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
9. Allegheny General Hospital Neurosurgeon Receives NIH Grant for Brain Aneurysm Research
10. Elsevier Promotes Local Research Efforts in Pakistan Through "Quiz for Science"
11. Researchers strike gold with nanotech vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... today announced the three Winners and six Finalists of the 2017 Blavatnik Regional ... by the Blavatnik Family Foundation and administered by the New York Academy of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... ... 2017 , ... Personal eye wash is a basic first aid supply for any work environment, ... eye do you rinse first if a dangerous substance enters both eyes? It’s one less ... with its unique dual eye piece. , “Whether its dirt and debris, or an acid ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):